Misonix (NASDAQ:MSON) opened at $10.00 on Friday. Misonix has a 12-month low of $7.05 and a 12-month high of $12.00.
Separately, TheStreet cut shares of Misonix from a “c-” rating to a “d” rating in a research report on Friday, February 9th.
A hedge fund recently raised its stake in Misonix stock. Northern Trust Corp raised its holdings in shares of Misonix, Inc. (NASDAQ:MSON) by 2.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,378 shares of the medical equipment provider’s stock after buying an additional 591 shares during the period. Northern Trust Corp owned about 0.27% of Misonix worth $233,000 at the end of the most recent reporting period. 11.03% of the stock is currently owned by hedge funds and other institutional investors.
Misonix, Inc designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company’s products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties.
Receive News & Ratings for Misonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Misonix and related companies with MarketBeat.com's FREE daily email newsletter.